Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT1A receptors in the rat medial frontal cortex
- 8 January 2002
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 40 (4) , 355-360
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Buspirone Augmentation of Antidepressant TherapyJournal of Clinical Psychopharmacology, 1998
- Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortexEuropean Journal of Pharmacology, 1998
- Potentiation of the Fluoxetine‐Induced Increase in Dialysate Levels of Serotonin (5‐HT) in the Frontal Cortex of Freely Moving Rats by Combined Blockade of 5‐HT1A and 5‐HT1B Receptors with WAY 100,635 and GR 127,935Journal of Neurochemistry, 1997
- Buspirone Enhances Duloxetine‐ and Fluoxetine‐Induced Increases in Dialysate Levels of Dopamine and Noradrenaline, but Not Serotonin, in the Frontal Cortex of Freely Moving RatsJournal of Neurochemistry, 1997
- Increased noradrenaline efflux induced by local infusion of fluoxetine in the rat frontal cortexEuropean Journal of Pharmacology, 1996
- Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depressionBiological Psychiatry, 1996
- Local Influence of Endogenous Norepinephrine on Extracellular Dopamine in Rat Medial Prefrontal CortexJournal of Neurochemistry, 1995
- Fluoxetine, a selective inhibitor of serotonin uptakeMedicinal Research Reviews, 1991
- Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic TerminalsJournal of Neurochemistry, 1990
- Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sitesBiological Psychiatry, 1990